首页|A metabolite from commensal Candida albicans enhances the bactericidal activity of macrophages and protects against sepsis

A metabolite from commensal Candida albicans enhances the bactericidal activity of macrophages and protects against sepsis

扫码查看
The gut microbiome is recognized as a key modulator of sepsis development.However,the contribution of the gut mycobiome to sepsis development is still not fully understood.Here,we demonstrated that the level of Candida albicans was markedly decreased in patients with bacterial sepsis,and the supernatant of Candida albicans culture significantly decreased the bacterial load and improved sepsis symptoms in both cecum ligation and puncture(CLP)-challenged mice and Escherichia coli-challenged pigs.Integrative metabolomics and the genetic engineering of fungi revealed that Candida albicans-derived phenylpyruvate(PPA)enhanced the bactericidal activity of macrophages and reduced organ damage during sepsis.Mechanistically,PPA directly binds to sirtuin 2(SIRT2)and increases reactive oxygen species(ROS)production for eventual bacterial clearance.Importantly,PPA enhanced the bacterial clearance capacity of macrophages in sepsis patients and was inversely correlated with the severity of sepsis in patients.Our findings highlight the crucial contribution of commensal fungi to bacterial disease modulation and expand our understanding of the host-mycobiome interaction during sepsis development.

Candida albicansPhenylpyruvateSepsisMacrophageBacterial clearance

Peng Gu、Ruofan Liu、Qin Yang、Li Xie、Rongjuan Wei、Jiaxin Li、Fengyi Mei、Tao Chen、Zhenhua Zeng、Yan He、Hongwei Zhou、Hongjuan Peng、Kutty Selva Nandakumar、Huikuan Chu、Yong Jiang、Wei Gong、Ye Chen、Bernd Schnabl、Peng Chen

展开 >

Department of Gastroenterology,Shenzhen Hospital,Southern Medical University,Shenzhen,China

Department of Pathophysiology,Guangdong Provincial Key Laboratory of Proteomics,School of Basic Medical Sciences,Southern Medical University,Guangzhou,China

Department of Gastroenterology,The Seventh Affiliated Hospital of Southern Medical University,Foshan,China

Department of Critical Care Medicine,Nanfang Hospital,Southern Medical University,Guangzhou,China

Microbiome Medicine Center,Zhujiang Hospital,Southern Medical University,Guangzhou,China

Department of Pathogen Biology,Guangdong Provincial Key Laboratory of Tropical Disease Research,School of Public Health,Southern Medical University,Guangzhou,China

Department of Environment and Biosciences,School of Business,Innovation and Sustainability,Halmstad University,Halmstad,Sweden

Division of Gastroenterology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China

Department of Medicine,University of California San Diego,La Jolla,CA,USA

展开 >

National Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNIHNational Natural Science Foundation of ChinaNational Key R&D Project of ChinaNational Natural Science Foundation of ChinaShenzhen Science and Technology ProgramResearch Foundation of Shenzhen Hospital of Southern Medical University

3227123032071124P30DK120515822705812018YFC011530181974070JCYJ20210324131010027PT2018GZR10

2023

中国免疫学杂志(英文版)
中国免疫学会

中国免疫学杂志(英文版)

CSTPCDCSCDSCI
影响因子:0.731
ISSN:1672-7681
年,卷(期):2023.20(10)
  • 59